Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2009-8-7
pubmed:abstractText
Chronic exposure to opioids leads to physical dependence, which manifests as the symptoms of drug withdrawal. Interindividual differences in withdrawal symptom severity are well known, and at least partially due to genetic variation. To identify genes contributing to variation in withdrawal severity, we chronically treated 30 strains of the AcB/BcA recombinant congenic mouse strain set, including their A/J and C57BL/6J (B6) progenitors, with morphine for seven days and compared jumping frequencies--a sensitive and widely used index of withdrawal magnitude--during naloxone-precipitated withdrawal (NPW). Jumping frequencies of B6 mice were more than threefold greater than values obtained in A/J mice. Visual inspection of the genomic distribution of parental haplotypes in the AcB/BcA strains identified a putative quantitative trait locus (QTL) localized to chromosome 8 (90-117 Mb), and this QTL was confirmed in a B6AF2 intercross. The most salient candidate gene within this QTL, Gnao1 (guanine nucleotide binding protein, alpha(o); G alpha(o); 96.3 Mb), was tested for functional relevance using quantitative PCR and an antisense oligodeoxynucleotide strategy. The expression of Gnao1 in the locus coeruleus was found to be upregulated in morphine-dependent B6 but not A/J mice. Antisense knockdown of Gnao1 reduced NPW jumping in B6, but not A/J, mice rendered dependent on either morphine or heroin, largely rescuing the original strain difference. These data strongly implicate the G alpha(o) protein in the locus coeruleus as contributing to interindividual variability in physical dependence on opioids in mice.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1873-7544
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
162
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1255-64
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:19460419-Animals, pubmed-meshheading:19460419-Chromosomes, Mammalian, pubmed-meshheading:19460419-Crosses, Genetic, pubmed-meshheading:19460419-GTP-Binding Protein alpha Subunits, Gi-Go, pubmed-meshheading:19460419-Gene Knockdown Techniques, pubmed-meshheading:19460419-Genetic Variation, pubmed-meshheading:19460419-Heroin Dependence, pubmed-meshheading:19460419-Locus Coeruleus, pubmed-meshheading:19460419-Male, pubmed-meshheading:19460419-Mice, pubmed-meshheading:19460419-Mice, Congenic, pubmed-meshheading:19460419-Morphine Dependence, pubmed-meshheading:19460419-Naloxone, pubmed-meshheading:19460419-Oligonucleotides, Antisense, pubmed-meshheading:19460419-Quantitative Trait Loci, pubmed-meshheading:19460419-Species Specificity, pubmed-meshheading:19460419-Substance Withdrawal Syndrome
pubmed:year
2009
pubmed:articleTitle
Gnao1 (G alphaO protein) is a likely genetic contributor to variation in physical dependence on opioids in mice.
pubmed:affiliation
Department of Psychology and Center for Developmental Neuroscience, The College of Staten Island, City University of New York, Staten Island, NY 10314, USA. kest@postbox.csi.cuny.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural